论文部分内容阅读
本文分析了900例肝脏疾患、血液及造血器官癌瘤患者的各种凝血系统实验室数据,并与53例具有典型临床特征的DIC患者进行了对比。这些实验室数据包括测定凝血系统的血小板计数、凝血活酶时间、凝血酶原时间、凝血酶时间、肝透明质试验(Hepa-plastin test)、纤维蛋白原、第Ⅱ因子、第Ⅴ因子、第Ⅶ因子、第Ⅷ因子活性、第Ⅷ因子有关抗原及Ⅷ因子活性/Ⅷ因子抗原比率,测定纤维蛋白溶解系统的血清凝血酶时间(STT)、纤维蛋白原降解产物、纤维蛋白溶酶原及类凝血试验(硫酸精蛋白试验、乙醇
This article analyzes laboratory data from a variety of clotting systems in 900 patients with liver disease, hematologic and hematopoietic cancer and compares them with 53 DIC patients with typical clinical characteristics. These laboratory data include determination of platelet count, thromboplastin time, prothrombin time, thrombin time, Hepa-plastin test, fibrinogen, factor II, factor V, Fibrinolytic system, fibrinogen degradation products, fibrinogen, fibrinogen, fibrinogen, fibrinogen, fibrinogen, fibrinogen, fibrinogen and fibrinogen Blood coagulation test (protamine sulfate test, ethanol